Assistant Director, Legal Transformation & Enablement
🏢 Telix Pharmaceuticals (AMER)
Assistant Director, Legal Transformation & Enablement at Telix Pharmaceuticals (AMER). Location: USA- Remote.
Remote Jobs at Telix Pharmaceuticals (AMER)
Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases. You will be supporting the international roll-out of our approved prostate cancer imaging agent and helping us to advance our portfolio of late clinical-stage products that address significant unmet need in oncology and rare diseases.
1 open position
Frequently Asked Questions
Does Telix Pharmaceuticals (AMER) hire remote workers?
Yes — Telix Pharmaceuticals (AMER) currently has 1 open remote position listed on F5 Remote Jobs, updated directly from the company's own job board.
What kind of roles does Telix Pharmaceuticals (AMER) typically hire for?
Based on current open positions, Telix Pharmaceuticals (AMER) most often hires for Legal. This reflects live listings and can change as new roles open or close.
How do I apply to a job at Telix Pharmaceuticals (AMER)?
Click any open position below to view the full job description, then use the "Apply Now" link to apply directly on Telix Pharmaceuticals (AMER)'s own application page — F5 Remote Jobs does not process applications itself.
What does Telix Pharmaceuticals (AMER) do?
Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases. You will be supporting the international roll-out of our approved prostate cancer imaging agent and helping us to advance our portfolio of late clinical-stage products that address significant unmet need in oncology and rare diseases.